Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
431-01-002 / 431-01-002 MRI in Clinical Practice Abstract

MRI in Clinical Practice: Perfusion Biomarkers as Clinical Alternatives to PET for Glioma Management

Primary: Neuro - Tumors
Secondary: Contrast Mechanisms - Perfusion
431-01-002 · From Microstructure to Metabolism: Next-Generation MRI for Brain Tumors · Tuesday, 12 May, 8:20 AM–9:56 AM · Roof Terrace
431-01-002 · From Microstructure to Metabolism: Next-Generation MRI for Brain Tumors · Tuesday, 12 May, 8:20 AM–9:56 AM · Roof Terrace
Keywords: DSC & DCE Perfusion Brain Tumor Imaging Radiation Necrosis Prognostic biomarker
Accepted
Nadya Pyatigorskaya 1,2,3, Damien Galanaud3, Rivka Bendrihem4, Ahmed Idbaih1, Aurelie Kas5
1Paris Brain Institute - ICM, Inserm U1127, CNRS UMR 7225, Sorbonne Université, UMR S 1127, Paris, France
2Sorbonne University, AP-HP, Paris Brain Institute – ICM, Pitié Salpêtrière University Hospital, Paris, France
3Department of Neuroradiology, Pitié Salpêtrière Hospital, APHP, Paris, France
4Simago, Paris, France
5Sorbonne Université, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière, Paris, France
Presenting Author: Nadya Pyatigorskaya

Synopsis

Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Bell LC, Stokes AM, Quarles CC. Analysis of postprocessing steps for residue function dependent dynamic susceptibility contrast (DSC)-MRI biomarkers and their clinical impact on glioma grading for both 1.5 and 3T. J Magn Reson Imaging. 2020 Feb;51(2):547-553. doi: 10.1002/jmri.26837. Epub 2019 Jun 17. [doi]
2. Larsson HBW, Vestergaard MB, Lindberg U, Iversen HK, Cramer SP. Brain capillary transit time heterogeneity in healthy volunteers measured by dynamic contrast-enhanced T1 -weighted perfusion MRI. J Magn Reson Imaging. 2017 Jun;45(6):1809-1820. doi: 10.1002/jmri.25488. Epub 2016 Oct 12. [doi]
3. Sim Y, Choi SH, Lee N, Park YW, Ahn SS, Chang JH, Kim SH, Lee SK. Clinical, qualitative imaging biomarkers, and tumor oxygenation imaging biomarkers for differentiation of midline-located IDH wild-type glioblastomas and H3 K27-altered diffuse midline gliomas in adults. Eur J Radiol. 2024 Apr;173:111384. doi: 10.1016/j.ejrad.2024.111384. Epub 2024 Feb 18. [doi]
4. Hansen MB, Tietze A, Kalpathy-Cramer J, Gerstner ER, Batchelor TT, Østergaard L, Mouridsen K. Reliable estimation of microvascular flow patterns in patients with disrupted blood-brain barrier using dynamic susceptibility contrast MRI. J Magn Reson Imaging. 2017 Aug;46(2):537-549. doi: 10.1002/jmri.25549. Epub 2016 Nov 30. [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/431-01-002